The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Subscribe To Our Newsletter & Stay Updated
